Skip to main content
. 2018 Aug 15;8:12190. doi: 10.1038/s41598-018-30740-y

Table 1.

General characteristics of newly-diagnosed diabetic patients (study participants) according to the proportion of days covered (PDC) (N = 65,067, % in column).

N Proportion of days covered (PDC) (2006–2007)
≥0.80 0.60–0.79 0.40–0.59 0.20–0.39 <0.20
N % N % N % N % N %
Total (% in row) 65,067 22,261 34.2 11,459 17.6 10,279 15.8 10,393 16.0 10,675 16.4
Sex
Men 39,808 13,227 59.4 7,014 61.2 6,416 62.4 6,474 62.3 6,677 62.6
Women 25,259 9,034 40.6 4,445 38.8 3,863 37.6 3,919 37.7 3,998 37.5
Age
40–49 18,752 5,634 25.3 3,555 31.0 3,079 30.0 3,213 30.9 3,271 30.6
50–59 22,173 7,844 35.2 3,934 34.3 3,558 34.6 3,429 33.0 3,408 31.9
60–69 16,524 6,191 27.8 2,766 24.1 2,503 24.4 2,478 23.8 2,586 24.2
70+ 7,618 2,592 11.6 1,204 10.5 1,139 11.1 1,273 12.3 1,410 13.2
Insurance type
The self-employed 21,042 6,552 29.4 3,791 33.1 3,482 33.9 3,506 33.7 3,711 34.8
Families of the self-employed 8,713 2,990 13.4 1,551 13.5 1,379 13.4 1,406 13.5 1,387 13.0
The employ insured 13,586 4,734 21.3 2,453 21.4 2,081 20.3 2,160 20.8 2,158 20.2
Dependents of the employ insured 21,726 7,985 35.9 3,664 32.0 3,337 32.5 3,321 32.0 3,419 32.0
Monthly contribution (KRW)
<20,000 9,021 2,900 13.0 1,647 14.4 1,489 14.5 1,446 13.9 1,539 14.4
20,000–39,999 15,817 5,205 23.4 2,837 24.8 2,511 24.4 2,594 25.0 2,670 25.0
40,000–59,999 12,435 4,231 19.0 2,151 18.8 2,003 19.5 1,989 19.1 2,061 19.3
60,000–79,999 10,326 3,593 16.1 1,819 15.9 1,577 15.3 1,615 15.5 1,722 16.1
80,000–99,999 6,848 2,447 11.0 1,194 10.4 1,022 9.9 1,050 10.1 1,135 10.6
100,000+ 10,620 3,885 17.5 1,811 15.8 1,677 16.3 1,699 16.4 1,548 14.5
Charlson Comorbidity Index (2002–2004)
0 49,634 17,325 77.8 8,790 76.7 7,790 75.8 7,803 75.1 7,926 74.3
1 12,199 3,916 17.6 2,139 18.7 1,959 19.1 2,035 19.6 2,150 20.1
2+ 3,234 1,020 4.6 530 4.6 530 5.2 555 5.3 599 5.6
Disability
No 61,218 21,029 94.5 10,820 94.4 9,631 93.7 9,781 94.1 9,957 93.3
Yes 3,849 1,232 5.5 639 5.6 648 6.3 612 5.9 718 6.7
Medical institution type (2006–2007)
Tertiary hospital 13,192 5,418 24.3 2,176 19.0 1,800 17.5 1,917 18.5 1,881 17.6
Secondary hospital 5,541 1,472 6.6 1,023 8.9 977 9.5 996 9.6 1,073 10.1
Clinic 41,209 13,275 59.6 7,417 64.7 6,847 66.6 6,729 64.8 6,941 65.0
Public health center 5,125 2,096 9.4 843 7.4 655 6.4 751 7.2 780 7.3
Main active ingredient of oral hypoglycemic agent (2006–2007)
Biguanide 14,605 5,189 23.3 2,502 21.8 2,166 21.1 2,297 22.1 2,451 23.0
Sulfonylurea 28,625 9,324 41.9 5,011 43.7 4,716 45.9 4,684 45.1 4,890 45.8
Others 21,837 7,748 34.8 3,946 34.4 3,397 33.1 3,412 32.8 3,334 31.2
Hypertension (2005–2007)
No 33,264 11,357 51.0 6,243 54.5 5,207 50.7 5,041 48.5 5,416 50.7
Yes 31,803 10,904 49.0 5,216 45.5 5,072 49.3 5,352 51.5 5,259 49.3
Main outcome (2008–2017)
Death 9,161 2,728 12.3 1,513 13.2 1,484 14.4 1,617 15.6 1,819 17.0
Cerebrovascular disease 5,286 1,584 7.1 906 7.9 829 8.1 948 9.1 1,019 9.6
Myocardial infarction 1,294 426 1.9 229 2.0 199 1.9 237 2.3 203 1.9

*The age, sex, disability, insurance type, and monthly contributions are taken from 2006.